Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

15.50
Delayed Data
As of Oct 20
 +0.55 / +3.68%
Today’s Change
12.21
Today|||52-Week Range
20.85
+18.32%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close14.95
Today’s open15.00
Day’s range14.55 - 15.60
Volume915,623
Average volume (3 months)763,467
Market cap$809.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+22.69%
Earnings growth (next 5 years)+44.06%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.23-4.09%
ACORAcorda Therapeutics ...+0.50+1.87%
ATNXAthenex Inc+0.05+0.29%
BYSIBeyondspring Inc-6.01-17.17%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts